Leonard JP - Search Results

1

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.

Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, Nos G, Sorokina M, Maksimov V, Sboner A, Sigouros M, van Besien K, Horwitz S, Rutherford SC, Mulvey E, Revuelta MV, Xiang J, Alonso A, Melnick A, Elemento O, Inghirami G, Leonard JP, Cerchietti L, Martin P. Ruan J, et al. Among authors: leonard jp. Blood. 2023 May 4;141(18):2194-2205. doi: 10.1182/blood.2022018254. Blood. 2023. PMID: 36796016 Free PMC article. Clinical Trial.

2

New developments in immunotherapy for non-Hodgkin's lymphoma.

Leonard JP, Furman RR, Ruan J, Coleman M. Leonard JP, et al. Curr Oncol Rep. 2005 Sep;7(5):364-71. doi: 10.1007/s11912-005-0063-4. Curr Oncol Rep. 2005. PMID: 16091197 Review.

3

Mantle cell lymphoma: current concept in biology and treatment.

Ruan J, Leonard JP. Ruan J, et al. Among authors: leonard jp. Cancer Treat Res. 2006;131:141-59. doi: 10.1007/978-0-387-29346-2_5. Cancer Treat Res. 2006. PMID: 16704169 Review. No abstract available.

4

IL-4 as therapy for non-Hodgkin's lymphoma: possibilities but major challenges.

Martin P, Leonard JP. Martin P, et al. Among authors: leonard jp. Leuk Lymphoma. 2007 Jul;48(7):1259-60. doi: 10.1080/10428190701416481. Leuk Lymphoma. 2007. PMID: 17613750 No abstract available.

5

Novel therapeutic targets in mantle cell lymphoma.

Martin P, Leonard JP. Martin P, et al. Among authors: leonard jp. Expert Opin Ther Targets. 2007 Jul;11(7):929-40. doi: 10.1517/14728222.11.7.929. Expert Opin Ther Targets. 2007. PMID: 17614761 Review.

6

Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphoma.

Martin P, Furman RR, Coleman M, Leonard JP. Martin P, et al. Among authors: leonard jp. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5636s-5642s. doi: 10.1158/1078-0432.CCR-07-1085. Clin Cancer Res. 2007. PMID: 17875800 Review.

7

Targeted therapies for non-Hodgkin lymphoma: rationally designed combinations.

Martin P, Leonard JP. Martin P, et al. Among authors: leonard jp. Clin Lymphoma Myeloma. 2007 Aug;7 Suppl 5:S192-8. doi: 10.3816/clm.2007.s.022. Clin Lymphoma Myeloma. 2007. PMID: 17877844 Review.

8

Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Leonard J, Kaufmann T. Coleman M, et al. Leuk Lymphoma. 2008 Mar;49(3):447-50. doi: 10.1080/10428190701837330. Leuk Lymphoma. 2008. PMID: 18297520

9

Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Kaufman TP, Leonard JP. Coleman M, et al. Among authors: leonard jp. Cancer. 2008 May 15;112(10):2228-32. doi: 10.1002/cncr.23422. Cancer. 2008. PMID: 18338745 Free article. Clinical Trial.

10

Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.

Martin P, Furman RR, Ruan J, Elstrom R, Barrientos J, Niesvizky R, Coleman M, Leonard JP. Martin P, et al. Among authors: leonard jp. Semin Hematol. 2008 Apr;45(2):126-32. doi: 10.1053/j.seminhematol.2008.02.007. Semin Hematol. 2008. PMID: 18381108 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page